Oncofertility care in young women and the outcomes of pregnancy over the last 5 years.
GnRH agonist
cancer survivors
cryopreservation of oocytes
cryopreservation of ovarian tissues
oncofertility care
Journal
Future science OA
ISSN: 2056-5623
Titre abrégé: Future Sci OA
Pays: England
ID NLM: 101665030
Informations de publication
Date de publication:
02 Feb 2021
02 Feb 2021
Historique:
entrez:
5
4
2021
pubmed:
6
4
2021
medline:
6
4
2021
Statut:
epublish
Résumé
To ascertain the actual outcomes of oncofertility care in young women to provide more appropriate care. We analyzed the data of 67 female patients under 43 years of age who underwent oncofertility care between January 2015 and September 2019. There were 28 patients with breast cancer, 19 patients with hematologic cancer and 20 patients with other cancer diagnoses. Breast cancer patients tended to take longer than hematologic cancer patients to initiate oncofertility treatment. Despite undergoing oncofertility care, seven of nine pregnant patients did not choose assisted reproductive technology (ART). As spontaneous pregnancies were more common than ART pregnancies in our study, pregnancy by not only ART but also non-ART method is a viable option for young cancer survivors.
Identifiants
pubmed: 33815825
doi: 10.2144/fsoa-2020-0169
pmc: PMC8015666
doi:
Types de publication
Journal Article
Langues
eng
Pagination
FSO680Informations de copyright
© 2021 Sayuri Takahashi.
Déclaration de conflit d'intérêts
Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.
Références
N Engl J Med. 2015 Mar 5;372(10):923-32
pubmed: 25738668
J Clin Oncol. 2006 Oct 20;24(30):4888-94
pubmed: 17015884
Fertil Steril. 2013 Jan;99(1):37-43
pubmed: 23083924
JAMA Surg. 2013 Jun;148(6):516-23
pubmed: 23615681
Reprod Med Biol. 2018 Jun 28;17(4):356-368
pubmed: 30377391
N Engl J Med. 2017 Oct 26;377(17):1657-1665
pubmed: 29069558
J Cancer Surviv. 2012 Dec;6(4):441-50
pubmed: 22956304
J Clin Oncol. 2015 Sep 20;33(27):2963-74
pubmed: 26304908
Fertil Steril. 2020 Aug;114(2):279-280
pubmed: 32741467
Hum Reprod Update. 2019 Mar 1;25(2):159-179
pubmed: 30462263
Cancer. 2015 Aug 1;121(15):2529-36
pubmed: 26054052
J Clin Oncol. 2016 Aug 1;34(22):2568-74
pubmed: 27217453
Reprod Biomed Online. 2005 Sep;11(3):300-8
pubmed: 16176668
J Clin Oncol. 2018 Jul 20;36(21):2169-2180
pubmed: 29874135
J Clin Oncol. 2018 Jul 20;36(21):2190-2197
pubmed: 29874134
Hum Reprod. 2018 Nov 1;33(11):2051-2059
pubmed: 27370358
Biosci Trends. 2018;12(5):463-469
pubmed: 30473553
Hum Reprod. 2018 Jul 1;33(7):1281-1290
pubmed: 29912328
Pediatr Endocrinol Diabetes Metab. 2019;25(3):144-149
pubmed: 31769272
Int J Clin Oncol. 2019 Jan;24(1):28-33
pubmed: 29502284
Hum Reprod. 2015 Mar;30(3):608-15
pubmed: 25567618
BMJ Open. 2019 Dec 15;9(12):e032505
pubmed: 31843840
Support Care Cancer. 2015 Feb;23(2):333-41
pubmed: 25082365
Lancet Oncol. 2014 Sep;15(10):1129-36
pubmed: 25130994
J Clin Oncol. 2015 Sep 20;33(27):2975-85
pubmed: 26304892
J Obstet Gynaecol Res. 2019 Oct;45(10):2021-2028
pubmed: 31364239
J Clin Endocrinol Metab. 2006 May;91(5):1723-8
pubmed: 16492690